| News Updates! |
| The appearance of news releases and external hyperlinks does not constitute endorsement by PER of the news release; linked Web sites; or information, products, or positions contained therein. |
Some smoking-related risks cut soon after quitting
| FDA Panel Doesn't Back Expanded Use Of Fentora
| AstraZeneca submits EU application for gefitinib in non-small cell lung cancer
| European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug
|
Read More >> |
| Journal Watch Updates! |
| Antiangiogenic Agents and Tumor Cavitation: Association With Squamous Histology but Not Hemoptysis in a Single-Institution Analysis | | May 8, 2008, 8:27 AM | J Thorac Oncol | PubMed |
|
| No Benefit With High-Dose Ifosfamide/Carboplatin/Etoposide in SCLC | | April 16, 2008, 8:34 AM | J Natl Cancer Inst | PubMed |
|
| Human Papillomavirus-Positive Head and Neck Cancer As a Distinct Disease Subtype Differences in Response to Treatment and Survival | | April 1, 2008, 8:23 AM | J Natl Cancer Inst | PubMed |
|
Read More >> |
|
|
